Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Limited has announced the issuance of 82,770 service rights under an employee incentive scheme, which are unquoted equity securities. These securities were issued on June 30, 2024, and are part of the company’s latest efforts to incentivize their workforce. The announcement was made public on July 2, 2024.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
